Cellectis (CLLS)
(Delayed Data from NSDQ)
$2.62 USD
-0.03 (-1.14%)
Updated Apr 23, 2024 03:59 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Cellectis SA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -98.69 | -125.11 | -97.48 | -115.21 |
Depreciation/Amortization & Depletion | NA | 18.44 | 16.57 | 9.82 | 6.88 |
Net Change from Assets/Liabilities | NA | -5.72 | -4.16 | -21.83 | 11.65 |
Net Cash from Discontinued Operations | NA | -18.60 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 17.13 | 8.14 | 29.23 | 27.54 |
Net Cash From Operating Activities | NA | -87.44 | -104.56 | -80.26 | -69.14 |
Property & Equipment | NA | -2.43 | -19.73 | -45.64 | -12.50 |
Acquisition/ Disposition of Subsidiaries | NA | -0.45 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.13 | 27.02 | -8.14 | -23.33 |
Other Investing Activities | NA | -0.01 | -0.01 | -0.57 | -0.05 |
Net Cash from Investing Activities | NA | -2.76 | 7.28 | -54.34 | -35.87 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -0.57 | 60.35 | 9.76 | -0.47 |
Issuance (Repayment) of Debt | NA | 4.41 | 0.00 | 24.17 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | -11.01 | -12.47 | -6.61 | -3.39 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 8.32 | -0.36 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 1.15 | 47.53 | 27.32 | -3.86 |
Effect of Exchange Rate Changes | NA | -3.36 | -5.75 | 7.91 | -2.10 |
Net Change In Cash & Equivalents | NA | -92.42 | -55.51 | -99.37 | -110.98 |
Cash at Beginning of Period | NA | 185.64 | 241.15 | 340.52 | 451.50 |
Cash at End of Period | NA | 93.22 | 185.64 | 241.15 | 340.52 |
Diluted Net EPS | NA | -2.33 | -2.55 | -1.91 | -2.41 |
Fiscal Year End for Cellectis SA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | NA | -53.21 | -35.73 | -27.83 |
Depreciation/Amortization & Depletion | NA | NA | 13.34 | 8.88 | 4.46 |
Net Change from Assets/Liabilities | NA | NA | -10.18 | -10.91 | -10.33 |
Net Cash from Discontinued Operations | NA | NA | -3.65 | -3.64 | -1.97 |
Other Operating Activities | NA | NA | -10.77 | -5.95 | 7.35 |
Net Cash From Operating Activities | NA | NA | -64.46 | -47.37 | -28.33 |
Property & Equipment | NA | NA | -0.80 | -0.48 | -0.21 |
Acquisition/ Disposition of Subsidiaries | NA | NA | 0.08 | 0.08 | 0.10 |
Investments | NA | NA | 0.49 | 0.49 | 0.35 |
Other Investing Activities | NA | NA | -1.63 | -1.64 | 0.00 |
Net Cash from Investing Activities | NA | NA | -1.86 | -1.56 | 0.23 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | NA | 23.61 | 23.56 | 23.39 |
Issuance (Repayment) of Debt | NA | NA | 24.45 | 19.96 | -1.27 |
Increase (Decrease) Short-Term Debt | NA | NA | -8.33 | -5.55 | -2.77 |
Payment of Dividends & Other Distributions | NA | NA | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | NA | 1.55 | 1.63 | 0.43 |
Net Cash from Financing Activities | NA | NA | 41.29 | 39.60 | 19.78 |
Effect of Exchange Rate Changes | NA | NA | -0.82 | 0.50 | 0.67 |
Net Change In Cash & Equivalents | NA | NA | -25.86 | -8.83 | -7.65 |
Cash at Beginning of Period | NA | NA | 93.22 | 93.22 | 93.22 |
Cash at End of Period | NA | NA | 67.36 | 84.39 | 85.57 |
Diluted Net EPS | NA | NA | -0.31 | -0.19 | -0.58 |